CVS Health Corporation filed its quarterly report on Form 10-Q with the SEC on August 5, 2026, covering the three and six months ended June 30, 2026, disclosing revenue, earnings, and balance sheet data for the period.

Key Highlights

  • Total revenues of $106.1 billion for the three months ended June 30, 2026, compared to $98.9 billion in the same period of 2025, according to the filing.
  • Net income attributable to CVS Health of $2,979 million for Q2 2026, up from $1,021 million in Q2 2025, as reported in the condensed consolidated statements of operations.
  • Diluted earnings per share of $2.31 for the second quarter of 2026, compared to $0.80 in the second quarter of 2025.
  • Six-month total revenues reached $206,522 million, versus $193,503 million for the six months ended June 30, 2025.
  • Operating cash flow of $10,594 million for the six months ended June 30, 2026, compared to $6,453 million in the prior-year period.
  • Total assets stood at $253,768 million as of June 30, 2026, with cash and cash equivalents of $11,329 million.
  • 1,278,970,369 shares of common stock were issued and outstanding as of July 29, 2026, per the filing's cover page.

CVS Health Q2 2026: Revenue Growth and Earnings Detail

According to the filing, CVS Health Corporation (NYSE: CVS) reported total revenues of $106,096 million for the three months ended June 30, 2026, up from $98,915 million in the comparable prior-year quarter. The company disclosed that product revenues were $66,219 million, premiums were $35,117 million, services revenues were $4,119 million, and net investment income was $641 million for the second quarter of 2026.

The filing reported operating income of $4,703 million for Q2 2026, compared to $2,381 million in Q2 2025. After interest expense of $757 million and other income of $31 million, income before income tax provision was $3,977 million. The company recorded an income tax provision of $982 million, resulting in net income of $2,995 million for the quarter. Net income attributable to CVS Health was $2,979 million, with diluted earnings per share of $2.31, based on weighted average diluted shares outstanding of 1,287 million.

On the balance sheet as of June 30, 2026, the company reported total assets of $253,768 million, including goodwill of $85,478 million and intangible assets, net, of $24,644 million. Total liabilities were $173,869 million, and total shareholders' equity was $79,899 million. The filing disclosed that long-term debt was $59,452 million and the current portion of long-term debt was $1,958 million. For the six months ended June 30, 2026, the company reported repayments of long-term debt of $3,287 million and dividends paid of $1,725 million.

What Was Disclosed

CVS Health's 10-Q for the quarter ended June 30, 2026, disclosed condensed consolidated statements of operations, comprehensive income, balance sheets, and cash flows, covering both second-quarter and first-half 2026 results compared to the corresponding 2025 periods.